Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Parasomnias × nabiximols × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 8 Neoplasms 6 Cancer Pain 4 Marijuana Abuse 2 Signs and Symptoms 1 Parasomnias 1 Neuralgia 1 Nausea 1 Multiple Sclerosis 1 Marijuana Use 1 Diabetes Mellitus 1 Anxiety Disorders 1 1- Cancer Patients During Chemotherapy Treatment 1

Interventions

Surveys and Questionnaires 3 Melatonin 3 Yoga 2 Exercise 2 Control Groups 2 nabiximols 1 Sugars 1 Modafinil 1 Minocycline 1 Mindfulness 1 Massage 1 Exercise Movement Techniques 1 Dronabinol 1 Cannabidiol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03948074 2025-09-10

CAFCARS

British Columbia Cancer Agency

Phase 2 Completed

Anxiety Disorders, Nausea, Pain, Parasomnias

Data powered by HemOnc (CC BY 4.0) Colophon ⚡